Medtronic launches Avila interbody fusion device in Europe


Medtronic has launched the Avila interbody fusion device for levels L2-S1 in open and minimally invasive anterior lumbar interbody fusion and oblique lateral interbody fusion procedures.

The Avila family of devices uses technology developed by Gary K Michelson.

Avila is designed to offer a wide range of lordotic options up to 24 degrees and an anatomical shape to provide the support to realign the spine. Titanium alloy properties are combined with large inner and lateral windows for bone grafting and post-operative fusion assessment, according to a company release.

Frank Hassel, orthopaedic surgeon at Loretto-Krankenhaus Hospital in Freiburg, Germany, commented after his first surgery with Avila, “Avila is straightforward to use, which eases even complex surgeries. I like the strong connection between cage and inserter during the impaction. I was able to adequately correct the lordosis and place a large amount of bone graft. These are necessary aspects to improve fusion and stability outcomes.”

Avila is provided in a compact kit with a unique dismountable inserter, allowing for easier sterilisation, making operating room management faster and reducing the time and cost of surgery.

Avila interbody fusion devices have CE-mark for use for interbody fusion with autogenous bone graft and/or bone graft substitute in adults with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. Eligible patients must have had at least six months of non-operative treatment for this condition. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. 

These devices are intended for use with supplemental fixation instrumentation, which has been cleared for use in the lumbar spine.